BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SHR-9539 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SHR-9539\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06484777-3426@assetmemo.bio
DTSTAMP:20261121T005818Z
DTSTART;VALUE=DATE:20270731
DTEND;VALUE=DATE:20270801
SUMMARY:SHR-9539: Phase 1 readout est. (NCT06484777)
DESCRIPTION:SHR-9539\, phase 1\, Multiple Myeloma.\nStudy: A Clinical Study
  of SHR-9539 in Patients With Multiple Myeloma\nEstimated primary completi
 on: 31 July 2027. This is a ClinicalTrials.gov estimate\, not a confirmed 
 readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/shr
 -9539#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/N
 CT06484777
URL:https://assetmemo.bio/drug/shr-9539#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
